Physical appearance concerns are uniquely associated with the severity of steroid dependence and depression in anabolic–androgenic steroid users Article Swipe
Scott Griffiths
,
Brendan Jacka
,
Louisa Degenhardt
,
Stuart B. Murray
,
Briony Larance
·
YOU?
·
· 2018
· Open Access
·
· DOI: https://doi.org/10.1111/dar.12688
YOU?
·
· 2018
· Open Access
·
· DOI: https://doi.org/10.1111/dar.12688
Introduction and Aims Emerging research suggests that the sub‐population of anabolic–androgenic steroid (AAS) users who experience physical appearance concerns may suffer greater psychological dysfunction than other sub‐populations, including users with athletic or occupational concerns. Thus, among current AAS users, we sought to determine whether, and to what extent, social physique anxiety—an established measure of appearance concern—was associated with psychological dysfunction. Design and Methods Interviews were conducted with a sample of 74 male AAS users living in Australia. Users completed self‐report instruments of the severity of AAS dependence, depression, hazardous and risky drinking, use of non‐AAS illicit drugs, psychological side‐effects due to AAS use and abnormal test results due to AAS use. Results Multivariate analyses revealed that greater social physique anxiety was uniquely associated with more severe symptoms of both AAS dependence and depression. Moreover, the effect size of these relationships was large. Social physique anxiety was not associated with hazardous or risky drinking, non‐AAS illicit drug use, psychological side‐effects or abnormal test results. Discussion and Conclusions Limitations notwithstanding, the study is consistent with the notion that AAS users who experience appearance concerns are at heightened risk of co‐morbid psychological dysfunction. Given trends indicating an increase in the prevalence of AAS use in Australia and elsewhere, the findings suggest that health‐care systems may need to consider prioritising the sub‐population of AAS users who experience appearance concerns. Further investigation of the clinical syndrome of AAS dependence is required, including its relation to body image and eating disorders.
Related Topics
Concepts
Metadata
- Type
- article
- Language
- en
- Landing Page
- https://doi.org/10.1111/dar.12688
- https://onlinelibrary.wiley.com/doi/pdfdirect/10.1111/dar.12688
- OA Status
- bronze
- Cited By
- 47
- References
- 38
- Related Works
- 10
- OpenAlex ID
- https://openalex.org/W2790537437
All OpenAlex metadata
Raw OpenAlex JSON
- OpenAlex ID
-
https://openalex.org/W2790537437Canonical identifier for this work in OpenAlex
- DOI
-
https://doi.org/10.1111/dar.12688Digital Object Identifier
- Title
-
Physical appearance concerns are uniquely associated with the severity of steroid dependence and depression in anabolic–androgenic steroid usersWork title
- Type
-
articleOpenAlex work type
- Language
-
enPrimary language
- Publication year
-
2018Year of publication
- Publication date
-
2018-02-27Full publication date if available
- Authors
-
Scott Griffiths, Brendan Jacka, Louisa Degenhardt, Stuart B. Murray, Briony LaranceList of authors in order
- Landing page
-
https://doi.org/10.1111/dar.12688Publisher landing page
- PDF URL
-
https://onlinelibrary.wiley.com/doi/pdfdirect/10.1111/dar.12688Direct link to full text PDF
- Open access
-
YesWhether a free full text is available
- OA status
-
bronzeOpen access status per OpenAlex
- OA URL
-
https://onlinelibrary.wiley.com/doi/pdfdirect/10.1111/dar.12688Direct OA link when available
- Concepts
-
Anxiety, Depression (economics), Population, Psychology, Clinical psychology, Anabolic steroid, Psychiatry, Steroid use, Anabolic-Androgenic Steroids, Medicine, Anabolism, Environmental health, Internal medicine, Economics, MacroeconomicsTop concepts (fields/topics) attached by OpenAlex
- Cited by
-
47Total citation count in OpenAlex
- Citations by year (recent)
-
2025: 6, 2024: 3, 2023: 9, 2022: 7, 2021: 9Per-year citation counts (last 5 years)
- References (count)
-
38Number of works referenced by this work
- Related works (count)
-
10Other works algorithmically related by OpenAlex
Full payload
| id | https://openalex.org/W2790537437 |
|---|---|
| doi | https://doi.org/10.1111/dar.12688 |
| ids.doi | https://doi.org/10.1111/dar.12688 |
| ids.mag | 2790537437 |
| ids.pmid | https://pubmed.ncbi.nlm.nih.gov/29484740 |
| ids.openalex | https://openalex.org/W2790537437 |
| fwci | 4.52041371 |
| mesh[0].qualifier_ui | |
| mesh[0].descriptor_ui | D000328 |
| mesh[0].is_major_topic | False |
| mesh[0].qualifier_name | |
| mesh[0].descriptor_name | Adult |
| mesh[1].qualifier_ui | Q000008 |
| mesh[1].descriptor_ui | D045930 |
| mesh[1].is_major_topic | False |
| mesh[1].qualifier_name | administration & dosage |
| mesh[1].descriptor_name | Anabolic Agents |
| mesh[2].qualifier_ui | Q000009 |
| mesh[2].descriptor_ui | D045930 |
| mesh[2].is_major_topic | False |
| mesh[2].qualifier_name | adverse effects |
| mesh[2].descriptor_name | Anabolic Agents |
| mesh[3].qualifier_ui | Q000523 |
| mesh[3].descriptor_ui | D001828 |
| mesh[3].is_major_topic | False |
| mesh[3].qualifier_name | psychology |
| mesh[3].descriptor_name | Body Image |
| mesh[4].qualifier_ui | |
| mesh[4].descriptor_ui | D003430 |
| mesh[4].is_major_topic | False |
| mesh[4].qualifier_name | |
| mesh[4].descriptor_name | Cross-Sectional Studies |
| mesh[5].qualifier_ui | Q000175 |
| mesh[5].descriptor_ui | D003863 |
| mesh[5].is_major_topic | False |
| mesh[5].qualifier_name | diagnosis |
| mesh[5].descriptor_name | Depression |
| mesh[6].qualifier_ui | Q000453 |
| mesh[6].descriptor_ui | D003863 |
| mesh[6].is_major_topic | False |
| mesh[6].qualifier_name | epidemiology |
| mesh[6].descriptor_name | Depression |
| mesh[7].qualifier_ui | Q000523 |
| mesh[7].descriptor_ui | D003863 |
| mesh[7].is_major_topic | False |
| mesh[7].qualifier_name | psychology |
| mesh[7].descriptor_name | Depression |
| mesh[8].qualifier_ui | |
| mesh[8].descriptor_ui | D006801 |
| mesh[8].is_major_topic | False |
| mesh[8].qualifier_name | |
| mesh[8].descriptor_name | Humans |
| mesh[9].qualifier_ui | |
| mesh[9].descriptor_ui | D008297 |
| mesh[9].is_major_topic | False |
| mesh[9].qualifier_name | |
| mesh[9].descriptor_name | Male |
| mesh[10].qualifier_ui | Q000453 |
| mesh[10].descriptor_ui | D009517 |
| mesh[10].is_major_topic | False |
| mesh[10].qualifier_name | epidemiology |
| mesh[10].descriptor_name | New South Wales |
| mesh[11].qualifier_ui | Q000187 |
| mesh[11].descriptor_ui | D000067029 |
| mesh[11].is_major_topic | True |
| mesh[11].qualifier_name | drug effects |
| mesh[11].descriptor_name | Physical Appearance, Body |
| mesh[12].qualifier_ui | Q000502 |
| mesh[12].descriptor_ui | D000067029 |
| mesh[12].is_major_topic | True |
| mesh[12].qualifier_name | physiology |
| mesh[12].descriptor_name | Physical Appearance, Body |
| mesh[13].qualifier_ui | |
| mesh[13].descriptor_ui | D012720 |
| mesh[13].is_major_topic | False |
| mesh[13].qualifier_name | |
| mesh[13].descriptor_name | Severity of Illness Index |
| mesh[14].qualifier_ui | Q000008 |
| mesh[14].descriptor_ui | D013256 |
| mesh[14].is_major_topic | False |
| mesh[14].qualifier_name | administration & dosage |
| mesh[14].descriptor_name | Steroids |
| mesh[15].qualifier_ui | Q000009 |
| mesh[15].descriptor_ui | D013256 |
| mesh[15].is_major_topic | False |
| mesh[15].qualifier_name | adverse effects |
| mesh[15].descriptor_name | Steroids |
| mesh[16].qualifier_ui | Q000175 |
| mesh[16].descriptor_ui | D019966 |
| mesh[16].is_major_topic | False |
| mesh[16].qualifier_name | diagnosis |
| mesh[16].descriptor_name | Substance-Related Disorders |
| mesh[17].qualifier_ui | Q000453 |
| mesh[17].descriptor_ui | D019966 |
| mesh[17].is_major_topic | False |
| mesh[17].qualifier_name | epidemiology |
| mesh[17].descriptor_name | Substance-Related Disorders |
| mesh[18].qualifier_ui | Q000523 |
| mesh[18].descriptor_ui | D019966 |
| mesh[18].is_major_topic | False |
| mesh[18].qualifier_name | psychology |
| mesh[18].descriptor_name | Substance-Related Disorders |
| mesh[19].qualifier_ui | Q000008 |
| mesh[19].descriptor_ui | D045165 |
| mesh[19].is_major_topic | False |
| mesh[19].qualifier_name | administration & dosage |
| mesh[19].descriptor_name | Testosterone Congeners |
| mesh[20].qualifier_ui | Q000009 |
| mesh[20].descriptor_ui | D045165 |
| mesh[20].is_major_topic | False |
| mesh[20].qualifier_name | adverse effects |
| mesh[20].descriptor_name | Testosterone Congeners |
| mesh[21].qualifier_ui | |
| mesh[21].descriptor_ui | D055815 |
| mesh[21].is_major_topic | False |
| mesh[21].qualifier_name | |
| mesh[21].descriptor_name | Young Adult |
| mesh[22].qualifier_ui | |
| mesh[22].descriptor_ui | D000328 |
| mesh[22].is_major_topic | False |
| mesh[22].qualifier_name | |
| mesh[22].descriptor_name | Adult |
| mesh[23].qualifier_ui | Q000008 |
| mesh[23].descriptor_ui | D045930 |
| mesh[23].is_major_topic | False |
| mesh[23].qualifier_name | administration & dosage |
| mesh[23].descriptor_name | Anabolic Agents |
| mesh[24].qualifier_ui | Q000009 |
| mesh[24].descriptor_ui | D045930 |
| mesh[24].is_major_topic | False |
| mesh[24].qualifier_name | adverse effects |
| mesh[24].descriptor_name | Anabolic Agents |
| mesh[25].qualifier_ui | Q000523 |
| mesh[25].descriptor_ui | D001828 |
| mesh[25].is_major_topic | False |
| mesh[25].qualifier_name | psychology |
| mesh[25].descriptor_name | Body Image |
| mesh[26].qualifier_ui | |
| mesh[26].descriptor_ui | D003430 |
| mesh[26].is_major_topic | False |
| mesh[26].qualifier_name | |
| mesh[26].descriptor_name | Cross-Sectional Studies |
| mesh[27].qualifier_ui | Q000175 |
| mesh[27].descriptor_ui | D003863 |
| mesh[27].is_major_topic | False |
| mesh[27].qualifier_name | diagnosis |
| mesh[27].descriptor_name | Depression |
| mesh[28].qualifier_ui | Q000453 |
| mesh[28].descriptor_ui | D003863 |
| mesh[28].is_major_topic | False |
| mesh[28].qualifier_name | epidemiology |
| mesh[28].descriptor_name | Depression |
| mesh[29].qualifier_ui | Q000523 |
| mesh[29].descriptor_ui | D003863 |
| mesh[29].is_major_topic | False |
| mesh[29].qualifier_name | psychology |
| mesh[29].descriptor_name | Depression |
| mesh[30].qualifier_ui | |
| mesh[30].descriptor_ui | D006801 |
| mesh[30].is_major_topic | False |
| mesh[30].qualifier_name | |
| mesh[30].descriptor_name | Humans |
| mesh[31].qualifier_ui | |
| mesh[31].descriptor_ui | D008297 |
| mesh[31].is_major_topic | False |
| mesh[31].qualifier_name | |
| mesh[31].descriptor_name | Male |
| mesh[32].qualifier_ui | Q000453 |
| mesh[32].descriptor_ui | D009517 |
| mesh[32].is_major_topic | False |
| mesh[32].qualifier_name | epidemiology |
| mesh[32].descriptor_name | New South Wales |
| mesh[33].qualifier_ui | Q000187 |
| mesh[33].descriptor_ui | D000067029 |
| mesh[33].is_major_topic | True |
| mesh[33].qualifier_name | drug effects |
| mesh[33].descriptor_name | Physical Appearance, Body |
| mesh[34].qualifier_ui | Q000502 |
| mesh[34].descriptor_ui | D000067029 |
| mesh[34].is_major_topic | True |
| mesh[34].qualifier_name | physiology |
| mesh[34].descriptor_name | Physical Appearance, Body |
| mesh[35].qualifier_ui | |
| mesh[35].descriptor_ui | D012720 |
| mesh[35].is_major_topic | False |
| mesh[35].qualifier_name | |
| mesh[35].descriptor_name | Severity of Illness Index |
| mesh[36].qualifier_ui | Q000008 |
| mesh[36].descriptor_ui | D013256 |
| mesh[36].is_major_topic | False |
| mesh[36].qualifier_name | administration & dosage |
| mesh[36].descriptor_name | Steroids |
| mesh[37].qualifier_ui | Q000009 |
| mesh[37].descriptor_ui | D013256 |
| mesh[37].is_major_topic | False |
| mesh[37].qualifier_name | adverse effects |
| mesh[37].descriptor_name | Steroids |
| mesh[38].qualifier_ui | Q000175 |
| mesh[38].descriptor_ui | D019966 |
| mesh[38].is_major_topic | False |
| mesh[38].qualifier_name | diagnosis |
| mesh[38].descriptor_name | Substance-Related Disorders |
| mesh[39].qualifier_ui | Q000453 |
| mesh[39].descriptor_ui | D019966 |
| mesh[39].is_major_topic | False |
| mesh[39].qualifier_name | epidemiology |
| mesh[39].descriptor_name | Substance-Related Disorders |
| mesh[40].qualifier_ui | Q000523 |
| mesh[40].descriptor_ui | D019966 |
| mesh[40].is_major_topic | False |
| mesh[40].qualifier_name | psychology |
| mesh[40].descriptor_name | Substance-Related Disorders |
| mesh[41].qualifier_ui | Q000008 |
| mesh[41].descriptor_ui | D045165 |
| mesh[41].is_major_topic | False |
| mesh[41].qualifier_name | administration & dosage |
| mesh[41].descriptor_name | Testosterone Congeners |
| mesh[42].qualifier_ui | Q000009 |
| mesh[42].descriptor_ui | D045165 |
| mesh[42].is_major_topic | False |
| mesh[42].qualifier_name | adverse effects |
| mesh[42].descriptor_name | Testosterone Congeners |
| mesh[43].qualifier_ui | |
| mesh[43].descriptor_ui | D055815 |
| mesh[43].is_major_topic | False |
| mesh[43].qualifier_name | |
| mesh[43].descriptor_name | Young Adult |
| type | article |
| title | Physical appearance concerns are uniquely associated with the severity of steroid dependence and depression in anabolic–androgenic steroid users |
| biblio.issue | 5 |
| biblio.volume | 37 |
| biblio.last_page | 670 |
| biblio.first_page | 664 |
| topics[0].id | https://openalex.org/T11146 |
| topics[0].field.id | https://openalex.org/fields/27 |
| topics[0].field.display_name | Medicine |
| topics[0].score | 0.998199999332428 |
| topics[0].domain.id | https://openalex.org/domains/4 |
| topics[0].domain.display_name | Health Sciences |
| topics[0].subfield.id | https://openalex.org/subfields/2712 |
| topics[0].subfield.display_name | Endocrinology, Diabetes and Metabolism |
| topics[0].display_name | Hormonal and reproductive studies |
| topics[1].id | https://openalex.org/T10263 |
| topics[1].field.id | https://openalex.org/fields/32 |
| topics[1].field.display_name | Psychology |
| topics[1].score | 0.996999979019165 |
| topics[1].domain.id | https://openalex.org/domains/2 |
| topics[1].domain.display_name | Social Sciences |
| topics[1].subfield.id | https://openalex.org/subfields/3203 |
| topics[1].subfield.display_name | Clinical Psychology |
| topics[1].display_name | Eating Disorders and Behaviors |
| topics[2].id | https://openalex.org/T11542 |
| topics[2].field.id | https://openalex.org/fields/32 |
| topics[2].field.display_name | Psychology |
| topics[2].score | 0.9768000245094299 |
| topics[2].domain.id | https://openalex.org/domains/2 |
| topics[2].domain.display_name | Social Sciences |
| topics[2].subfield.id | https://openalex.org/subfields/3202 |
| topics[2].subfield.display_name | Applied Psychology |
| topics[2].display_name | Behavioral Health and Interventions |
| is_xpac | False |
| apc_list.value | 4220 |
| apc_list.currency | USD |
| apc_list.value_usd | 4220 |
| apc_paid | |
| concepts[0].id | https://openalex.org/C558461103 |
| concepts[0].level | 2 |
| concepts[0].score | 0.729308009147644 |
| concepts[0].wikidata | https://www.wikidata.org/wiki/Q154430 |
| concepts[0].display_name | Anxiety |
| concepts[1].id | https://openalex.org/C2776867660 |
| concepts[1].level | 2 |
| concepts[1].score | 0.674807071685791 |
| concepts[1].wikidata | https://www.wikidata.org/wiki/Q1814941 |
| concepts[1].display_name | Depression (economics) |
| concepts[2].id | https://openalex.org/C2908647359 |
| concepts[2].level | 2 |
| concepts[2].score | 0.5562044382095337 |
| concepts[2].wikidata | https://www.wikidata.org/wiki/Q2625603 |
| concepts[2].display_name | Population |
| concepts[3].id | https://openalex.org/C15744967 |
| concepts[3].level | 0 |
| concepts[3].score | 0.554067075252533 |
| concepts[3].wikidata | https://www.wikidata.org/wiki/Q9418 |
| concepts[3].display_name | Psychology |
| concepts[4].id | https://openalex.org/C70410870 |
| concepts[4].level | 1 |
| concepts[4].score | 0.5223820805549622 |
| concepts[4].wikidata | https://www.wikidata.org/wiki/Q199906 |
| concepts[4].display_name | Clinical psychology |
| concepts[5].id | https://openalex.org/C2779390809 |
| concepts[5].level | 3 |
| concepts[5].score | 0.5161615014076233 |
| concepts[5].wikidata | https://www.wikidata.org/wiki/Q309438 |
| concepts[5].display_name | Anabolic steroid |
| concepts[6].id | https://openalex.org/C118552586 |
| concepts[6].level | 1 |
| concepts[6].score | 0.48354053497314453 |
| concepts[6].wikidata | https://www.wikidata.org/wiki/Q7867 |
| concepts[6].display_name | Psychiatry |
| concepts[7].id | https://openalex.org/C2909375446 |
| concepts[7].level | 2 |
| concepts[7].score | 0.4754747450351715 |
| concepts[7].wikidata | https://www.wikidata.org/wiki/Q309438 |
| concepts[7].display_name | Steroid use |
| concepts[8].id | https://openalex.org/C2908663871 |
| concepts[8].level | 3 |
| concepts[8].score | 0.437194287776947 |
| concepts[8].wikidata | https://www.wikidata.org/wiki/Q309438 |
| concepts[8].display_name | Anabolic-Androgenic Steroids |
| concepts[9].id | https://openalex.org/C71924100 |
| concepts[9].level | 0 |
| concepts[9].score | 0.3753812909126282 |
| concepts[9].wikidata | https://www.wikidata.org/wiki/Q11190 |
| concepts[9].display_name | Medicine |
| concepts[10].id | https://openalex.org/C1008401 |
| concepts[10].level | 2 |
| concepts[10].score | 0.20273146033287048 |
| concepts[10].wikidata | https://www.wikidata.org/wiki/Q184681 |
| concepts[10].display_name | Anabolism |
| concepts[11].id | https://openalex.org/C99454951 |
| concepts[11].level | 1 |
| concepts[11].score | 0.1606447398662567 |
| concepts[11].wikidata | https://www.wikidata.org/wiki/Q932068 |
| concepts[11].display_name | Environmental health |
| concepts[12].id | https://openalex.org/C126322002 |
| concepts[12].level | 1 |
| concepts[12].score | 0.13931986689567566 |
| concepts[12].wikidata | https://www.wikidata.org/wiki/Q11180 |
| concepts[12].display_name | Internal medicine |
| concepts[13].id | https://openalex.org/C162324750 |
| concepts[13].level | 0 |
| concepts[13].score | 0.0 |
| concepts[13].wikidata | https://www.wikidata.org/wiki/Q8134 |
| concepts[13].display_name | Economics |
| concepts[14].id | https://openalex.org/C139719470 |
| concepts[14].level | 1 |
| concepts[14].score | 0.0 |
| concepts[14].wikidata | https://www.wikidata.org/wiki/Q39680 |
| concepts[14].display_name | Macroeconomics |
| keywords[0].id | https://openalex.org/keywords/anxiety |
| keywords[0].score | 0.729308009147644 |
| keywords[0].display_name | Anxiety |
| keywords[1].id | https://openalex.org/keywords/depression |
| keywords[1].score | 0.674807071685791 |
| keywords[1].display_name | Depression (economics) |
| keywords[2].id | https://openalex.org/keywords/population |
| keywords[2].score | 0.5562044382095337 |
| keywords[2].display_name | Population |
| keywords[3].id | https://openalex.org/keywords/psychology |
| keywords[3].score | 0.554067075252533 |
| keywords[3].display_name | Psychology |
| keywords[4].id | https://openalex.org/keywords/clinical-psychology |
| keywords[4].score | 0.5223820805549622 |
| keywords[4].display_name | Clinical psychology |
| keywords[5].id | https://openalex.org/keywords/anabolic-steroid |
| keywords[5].score | 0.5161615014076233 |
| keywords[5].display_name | Anabolic steroid |
| keywords[6].id | https://openalex.org/keywords/psychiatry |
| keywords[6].score | 0.48354053497314453 |
| keywords[6].display_name | Psychiatry |
| keywords[7].id | https://openalex.org/keywords/steroid-use |
| keywords[7].score | 0.4754747450351715 |
| keywords[7].display_name | Steroid use |
| keywords[8].id | https://openalex.org/keywords/anabolic-androgenic-steroids |
| keywords[8].score | 0.437194287776947 |
| keywords[8].display_name | Anabolic-Androgenic Steroids |
| keywords[9].id | https://openalex.org/keywords/medicine |
| keywords[9].score | 0.3753812909126282 |
| keywords[9].display_name | Medicine |
| keywords[10].id | https://openalex.org/keywords/anabolism |
| keywords[10].score | 0.20273146033287048 |
| keywords[10].display_name | Anabolism |
| keywords[11].id | https://openalex.org/keywords/environmental-health |
| keywords[11].score | 0.1606447398662567 |
| keywords[11].display_name | Environmental health |
| keywords[12].id | https://openalex.org/keywords/internal-medicine |
| keywords[12].score | 0.13931986689567566 |
| keywords[12].display_name | Internal medicine |
| language | en |
| locations[0].id | doi:10.1111/dar.12688 |
| locations[0].is_oa | True |
| locations[0].source.id | https://openalex.org/S134936136 |
| locations[0].source.issn | 0959-5236, 1465-3362 |
| locations[0].source.type | journal |
| locations[0].source.is_oa | False |
| locations[0].source.issn_l | 0959-5236 |
| locations[0].source.is_core | True |
| locations[0].source.is_in_doaj | False |
| locations[0].source.display_name | Drug and Alcohol Review |
| locations[0].source.host_organization | https://openalex.org/P4310320595 |
| locations[0].source.host_organization_name | Wiley |
| locations[0].source.host_organization_lineage | https://openalex.org/P4310320595 |
| locations[0].license | |
| locations[0].pdf_url | https://onlinelibrary.wiley.com/doi/pdfdirect/10.1111/dar.12688 |
| locations[0].version | publishedVersion |
| locations[0].raw_type | journal-article |
| locations[0].license_id | |
| locations[0].is_accepted | True |
| locations[0].is_published | True |
| locations[0].raw_source_name | Drug and Alcohol Review |
| locations[0].landing_page_url | https://doi.org/10.1111/dar.12688 |
| locations[1].id | pmid:29484740 |
| locations[1].is_oa | False |
| locations[1].source.id | https://openalex.org/S4306525036 |
| locations[1].source.issn | |
| locations[1].source.type | repository |
| locations[1].source.is_oa | False |
| locations[1].source.issn_l | |
| locations[1].source.is_core | False |
| locations[1].source.is_in_doaj | False |
| locations[1].source.display_name | PubMed |
| locations[1].source.host_organization | https://openalex.org/I1299303238 |
| locations[1].source.host_organization_name | National Institutes of Health |
| locations[1].source.host_organization_lineage | https://openalex.org/I1299303238 |
| locations[1].license | |
| locations[1].pdf_url | |
| locations[1].version | publishedVersion |
| locations[1].raw_type | |
| locations[1].license_id | |
| locations[1].is_accepted | True |
| locations[1].is_published | True |
| locations[1].raw_source_name | Drug and alcohol review |
| locations[1].landing_page_url | https://pubmed.ncbi.nlm.nih.gov/29484740 |
| locations[2].id | pmh:oai:jupiter.its.unimelb.edu.au:11343/283656 |
| locations[2].is_oa | False |
| locations[2].source.id | https://openalex.org/S4306402500 |
| locations[2].source.issn | |
| locations[2].source.type | repository |
| locations[2].source.is_oa | False |
| locations[2].source.issn_l | |
| locations[2].source.is_core | False |
| locations[2].source.is_in_doaj | False |
| locations[2].source.display_name | Minerva Access (University of Melbourne) |
| locations[2].source.host_organization | https://openalex.org/I165779595 |
| locations[2].source.host_organization_name | University of Melbourne |
| locations[2].source.host_organization_lineage | https://openalex.org/I165779595 |
| locations[2].license | |
| locations[2].pdf_url | |
| locations[2].version | submittedVersion |
| locations[2].raw_type | Journal Article |
| locations[2].license_id | |
| locations[2].is_accepted | False |
| locations[2].is_published | False |
| locations[2].raw_source_name | |
| locations[2].landing_page_url | http://hdl.handle.net/11343/283656 |
| indexed_in | crossref, pubmed |
| authorships[0].author.id | https://openalex.org/A5000633656 |
| authorships[0].author.orcid | https://orcid.org/0000-0002-6366-3560 |
| authorships[0].author.display_name | Scott Griffiths |
| authorships[0].countries | AU |
| authorships[0].affiliations[0].institution_ids | https://openalex.org/I165779595, https://openalex.org/I68435313 |
| authorships[0].affiliations[0].raw_affiliation_string | Melbourne School of Psychological Sciences University of Melbourne Melbourne Australia |
| authorships[0].institutions[0].id | https://openalex.org/I68435313 |
| authorships[0].institutions[0].ror | https://ror.org/038htga59 |
| authorships[0].institutions[0].type | other |
| authorships[0].institutions[0].lineage | https://openalex.org/I68435313 |
| authorships[0].institutions[0].country_code | AU |
| authorships[0].institutions[0].display_name | Australian Psychological Society |
| authorships[0].institutions[1].id | https://openalex.org/I165779595 |
| authorships[0].institutions[1].ror | https://ror.org/01ej9dk98 |
| authorships[0].institutions[1].type | education |
| authorships[0].institutions[1].lineage | https://openalex.org/I165779595 |
| authorships[0].institutions[1].country_code | AU |
| authorships[0].institutions[1].display_name | The University of Melbourne |
| authorships[0].author_position | first |
| authorships[0].raw_author_name | Scott Griffiths |
| authorships[0].is_corresponding | True |
| authorships[0].raw_affiliation_strings | Melbourne School of Psychological Sciences University of Melbourne Melbourne Australia |
| authorships[1].author.id | https://openalex.org/A5015979821 |
| authorships[1].author.orcid | https://orcid.org/0000-0002-5910-853X |
| authorships[1].author.display_name | Brendan Jacka |
| authorships[1].countries | AU |
| authorships[1].affiliations[0].institution_ids | https://openalex.org/I31746571, https://openalex.org/I4210136824 |
| authorships[1].affiliations[0].raw_affiliation_string | National Drug and Alcohol Research Centre University of New South Wales Sydney Australia |
| authorships[1].institutions[0].id | https://openalex.org/I4210136824 |
| authorships[1].institutions[0].ror | https://ror.org/04gfkf394 |
| authorships[1].institutions[0].type | facility |
| authorships[1].institutions[0].lineage | https://openalex.org/I4210136824 |
| authorships[1].institutions[0].country_code | AU |
| authorships[1].institutions[0].display_name | National Centre for Clinical Research on Emerging Drugs |
| authorships[1].institutions[1].id | https://openalex.org/I31746571 |
| authorships[1].institutions[1].ror | https://ror.org/03r8z3t63 |
| authorships[1].institutions[1].type | education |
| authorships[1].institutions[1].lineage | https://openalex.org/I31746571 |
| authorships[1].institutions[1].country_code | AU |
| authorships[1].institutions[1].display_name | UNSW Sydney |
| authorships[1].author_position | middle |
| authorships[1].raw_author_name | Brendan Jacka |
| authorships[1].is_corresponding | True |
| authorships[1].raw_affiliation_strings | National Drug and Alcohol Research Centre University of New South Wales Sydney Australia |
| authorships[2].author.id | https://openalex.org/A5007290128 |
| authorships[2].author.orcid | https://orcid.org/0000-0002-8513-2218 |
| authorships[2].author.display_name | Louisa Degenhardt |
| authorships[2].countries | AU |
| authorships[2].affiliations[0].institution_ids | https://openalex.org/I31746571, https://openalex.org/I4210136824 |
| authorships[2].affiliations[0].raw_affiliation_string | National Drug and Alcohol Research Centre University of New South Wales Sydney Australia |
| authorships[2].institutions[0].id | https://openalex.org/I4210136824 |
| authorships[2].institutions[0].ror | https://ror.org/04gfkf394 |
| authorships[2].institutions[0].type | facility |
| authorships[2].institutions[0].lineage | https://openalex.org/I4210136824 |
| authorships[2].institutions[0].country_code | AU |
| authorships[2].institutions[0].display_name | National Centre for Clinical Research on Emerging Drugs |
| authorships[2].institutions[1].id | https://openalex.org/I31746571 |
| authorships[2].institutions[1].ror | https://ror.org/03r8z3t63 |
| authorships[2].institutions[1].type | education |
| authorships[2].institutions[1].lineage | https://openalex.org/I31746571 |
| authorships[2].institutions[1].country_code | AU |
| authorships[2].institutions[1].display_name | UNSW Sydney |
| authorships[2].author_position | middle |
| authorships[2].raw_author_name | Louisa Degenhardt |
| authorships[2].is_corresponding | True |
| authorships[2].raw_affiliation_strings | National Drug and Alcohol Research Centre University of New South Wales Sydney Australia |
| authorships[3].author.id | https://openalex.org/A5090118852 |
| authorships[3].author.orcid | https://orcid.org/0000-0002-5588-2915 |
| authorships[3].author.display_name | Stuart B. Murray |
| authorships[3].countries | US |
| authorships[3].affiliations[0].institution_ids | https://openalex.org/I180670191 |
| authorships[3].affiliations[0].raw_affiliation_string | Department of Psychiatry University of California San Francisco USA |
| authorships[3].institutions[0].id | https://openalex.org/I180670191 |
| authorships[3].institutions[0].ror | https://ror.org/043mz5j54 |
| authorships[3].institutions[0].type | education |
| authorships[3].institutions[0].lineage | https://openalex.org/I180670191 |
| authorships[3].institutions[0].country_code | US |
| authorships[3].institutions[0].display_name | University of California, San Francisco |
| authorships[3].author_position | middle |
| authorships[3].raw_author_name | Stuart B. Murray |
| authorships[3].is_corresponding | True |
| authorships[3].raw_affiliation_strings | Department of Psychiatry University of California San Francisco USA |
| authorships[4].author.id | https://openalex.org/A5060125444 |
| authorships[4].author.orcid | https://orcid.org/0000-0003-3800-7673 |
| authorships[4].author.display_name | Briony Larance |
| authorships[4].countries | AU |
| authorships[4].affiliations[0].institution_ids | https://openalex.org/I31746571, https://openalex.org/I4210136824 |
| authorships[4].affiliations[0].raw_affiliation_string | National Drug and Alcohol Research Centre University of New South Wales Sydney Australia |
| authorships[4].institutions[0].id | https://openalex.org/I4210136824 |
| authorships[4].institutions[0].ror | https://ror.org/04gfkf394 |
| authorships[4].institutions[0].type | facility |
| authorships[4].institutions[0].lineage | https://openalex.org/I4210136824 |
| authorships[4].institutions[0].country_code | AU |
| authorships[4].institutions[0].display_name | National Centre for Clinical Research on Emerging Drugs |
| authorships[4].institutions[1].id | https://openalex.org/I31746571 |
| authorships[4].institutions[1].ror | https://ror.org/03r8z3t63 |
| authorships[4].institutions[1].type | education |
| authorships[4].institutions[1].lineage | https://openalex.org/I31746571 |
| authorships[4].institutions[1].country_code | AU |
| authorships[4].institutions[1].display_name | UNSW Sydney |
| authorships[4].author_position | last |
| authorships[4].raw_author_name | Briony Larance |
| authorships[4].is_corresponding | True |
| authorships[4].raw_affiliation_strings | National Drug and Alcohol Research Centre University of New South Wales Sydney Australia |
| has_content.pdf | True |
| has_content.grobid_xml | True |
| is_paratext | False |
| open_access.is_oa | True |
| open_access.oa_url | https://onlinelibrary.wiley.com/doi/pdfdirect/10.1111/dar.12688 |
| open_access.oa_status | bronze |
| open_access.any_repository_has_fulltext | False |
| created_date | 2025-10-10T00:00:00 |
| display_name | Physical appearance concerns are uniquely associated with the severity of steroid dependence and depression in anabolic–androgenic steroid users |
| has_fulltext | True |
| is_retracted | False |
| updated_date | 2025-11-06T03:46:38.306776 |
| primary_topic.id | https://openalex.org/T11146 |
| primary_topic.field.id | https://openalex.org/fields/27 |
| primary_topic.field.display_name | Medicine |
| primary_topic.score | 0.998199999332428 |
| primary_topic.domain.id | https://openalex.org/domains/4 |
| primary_topic.domain.display_name | Health Sciences |
| primary_topic.subfield.id | https://openalex.org/subfields/2712 |
| primary_topic.subfield.display_name | Endocrinology, Diabetes and Metabolism |
| primary_topic.display_name | Hormonal and reproductive studies |
| related_works | https://openalex.org/W2025363664, https://openalex.org/W2160026650, https://openalex.org/W346680113, https://openalex.org/W3165332414, https://openalex.org/W4309340398, https://openalex.org/W2133323889, https://openalex.org/W1994901678, https://openalex.org/W2318751823, https://openalex.org/W2231982343, https://openalex.org/W2158708602 |
| cited_by_count | 47 |
| counts_by_year[0].year | 2025 |
| counts_by_year[0].cited_by_count | 6 |
| counts_by_year[1].year | 2024 |
| counts_by_year[1].cited_by_count | 3 |
| counts_by_year[2].year | 2023 |
| counts_by_year[2].cited_by_count | 9 |
| counts_by_year[3].year | 2022 |
| counts_by_year[3].cited_by_count | 7 |
| counts_by_year[4].year | 2021 |
| counts_by_year[4].cited_by_count | 9 |
| counts_by_year[5].year | 2020 |
| counts_by_year[5].cited_by_count | 6 |
| counts_by_year[6].year | 2019 |
| counts_by_year[6].cited_by_count | 7 |
| locations_count | 3 |
| best_oa_location.id | doi:10.1111/dar.12688 |
| best_oa_location.is_oa | True |
| best_oa_location.source.id | https://openalex.org/S134936136 |
| best_oa_location.source.issn | 0959-5236, 1465-3362 |
| best_oa_location.source.type | journal |
| best_oa_location.source.is_oa | False |
| best_oa_location.source.issn_l | 0959-5236 |
| best_oa_location.source.is_core | True |
| best_oa_location.source.is_in_doaj | False |
| best_oa_location.source.display_name | Drug and Alcohol Review |
| best_oa_location.source.host_organization | https://openalex.org/P4310320595 |
| best_oa_location.source.host_organization_name | Wiley |
| best_oa_location.source.host_organization_lineage | https://openalex.org/P4310320595 |
| best_oa_location.license | |
| best_oa_location.pdf_url | https://onlinelibrary.wiley.com/doi/pdfdirect/10.1111/dar.12688 |
| best_oa_location.version | publishedVersion |
| best_oa_location.raw_type | journal-article |
| best_oa_location.license_id | |
| best_oa_location.is_accepted | True |
| best_oa_location.is_published | True |
| best_oa_location.raw_source_name | Drug and Alcohol Review |
| best_oa_location.landing_page_url | https://doi.org/10.1111/dar.12688 |
| primary_location.id | doi:10.1111/dar.12688 |
| primary_location.is_oa | True |
| primary_location.source.id | https://openalex.org/S134936136 |
| primary_location.source.issn | 0959-5236, 1465-3362 |
| primary_location.source.type | journal |
| primary_location.source.is_oa | False |
| primary_location.source.issn_l | 0959-5236 |
| primary_location.source.is_core | True |
| primary_location.source.is_in_doaj | False |
| primary_location.source.display_name | Drug and Alcohol Review |
| primary_location.source.host_organization | https://openalex.org/P4310320595 |
| primary_location.source.host_organization_name | Wiley |
| primary_location.source.host_organization_lineage | https://openalex.org/P4310320595 |
| primary_location.license | |
| primary_location.pdf_url | https://onlinelibrary.wiley.com/doi/pdfdirect/10.1111/dar.12688 |
| primary_location.version | publishedVersion |
| primary_location.raw_type | journal-article |
| primary_location.license_id | |
| primary_location.is_accepted | True |
| primary_location.is_published | True |
| primary_location.raw_source_name | Drug and Alcohol Review |
| primary_location.landing_page_url | https://doi.org/10.1111/dar.12688 |
| publication_date | 2018-02-27 |
| publication_year | 2018 |
| referenced_works | https://openalex.org/W2001277036, https://openalex.org/W1993622967, https://openalex.org/W2083321104, https://openalex.org/W2171719429, https://openalex.org/W2429783932, https://openalex.org/W2012330969, https://openalex.org/W2020958032, https://openalex.org/W2016340979, https://openalex.org/W2071587512, https://openalex.org/W2560261225, https://openalex.org/W2169518725, https://openalex.org/W4255712677, https://openalex.org/W2593118516, https://openalex.org/W1915962233, https://openalex.org/W2765782124, https://openalex.org/W2538885189, https://openalex.org/W2467663663, https://openalex.org/W2160709659, https://openalex.org/W34403834, https://openalex.org/W2134306317, https://openalex.org/W2009347739, https://openalex.org/W2018820143, https://openalex.org/W1596527406, https://openalex.org/W1987094115, https://openalex.org/W2132322340, https://openalex.org/W2172036914, https://openalex.org/W2072500831, https://openalex.org/W1965290724, https://openalex.org/W1984700288, https://openalex.org/W2560578134, https://openalex.org/W2090830682, https://openalex.org/W2042075390, https://openalex.org/W2170185238, https://openalex.org/W2083114059, https://openalex.org/W2048190957, https://openalex.org/W1995854440, https://openalex.org/W2327251030, https://openalex.org/W2015479829 |
| referenced_works_count | 38 |
| abstract_inverted_index.a | 68 |
| abstract_inverted_index.74 | 71 |
| abstract_inverted_index.an | 194 |
| abstract_inverted_index.at | 184 |
| abstract_inverted_index.in | 76, 196, 202 |
| abstract_inverted_index.is | 171, 235 |
| abstract_inverted_index.of | 10, 54, 70, 82, 85, 94, 128, 138, 187, 199, 219, 228, 232 |
| abstract_inverted_index.or | 32, 151, 160 |
| abstract_inverted_index.to | 42, 46, 101, 109, 214, 240 |
| abstract_inverted_index.we | 40 |
| abstract_inverted_index.AAS | 38, 73, 86, 102, 110, 130, 177, 200, 220, 233 |
| abstract_inverted_index.and | 2, 45, 62, 90, 104, 132, 165, 204, 243 |
| abstract_inverted_index.are | 183 |
| abstract_inverted_index.due | 100, 108 |
| abstract_inverted_index.its | 238 |
| abstract_inverted_index.may | 20, 212 |
| abstract_inverted_index.not | 147 |
| abstract_inverted_index.the | 8, 83, 135, 169, 174, 197, 206, 217, 229 |
| abstract_inverted_index.use | 93, 103, 201 |
| abstract_inverted_index.was | 121, 141, 146 |
| abstract_inverted_index.who | 15, 179, 222 |
| abstract_inverted_index.Aims | 3 |
| abstract_inverted_index.body | 241 |
| abstract_inverted_index.both | 129 |
| abstract_inverted_index.drug | 156 |
| abstract_inverted_index.male | 72 |
| abstract_inverted_index.more | 125 |
| abstract_inverted_index.need | 213 |
| abstract_inverted_index.risk | 186 |
| abstract_inverted_index.size | 137 |
| abstract_inverted_index.test | 106, 162 |
| abstract_inverted_index.than | 25 |
| abstract_inverted_index.that | 7, 116, 176, 209 |
| abstract_inverted_index.use, | 157 |
| abstract_inverted_index.use. | 111 |
| abstract_inverted_index.were | 65 |
| abstract_inverted_index.what | 47 |
| abstract_inverted_index.with | 30, 58, 67, 124, 149, 173 |
| abstract_inverted_index.(AAS) | 13 |
| abstract_inverted_index.Given | 191 |
| abstract_inverted_index.Thus, | 35 |
| abstract_inverted_index.Users | 78 |
| abstract_inverted_index.among | 36 |
| abstract_inverted_index.image | 242 |
| abstract_inverted_index.other | 26 |
| abstract_inverted_index.risky | 91, 152 |
| abstract_inverted_index.study | 170 |
| abstract_inverted_index.these | 139 |
| abstract_inverted_index.users | 14, 29, 74, 178, 221 |
| abstract_inverted_index.Design | 61 |
| abstract_inverted_index.Social | 143 |
| abstract_inverted_index.drugs, | 97 |
| abstract_inverted_index.eating | 244 |
| abstract_inverted_index.effect | 136 |
| abstract_inverted_index.large. | 142 |
| abstract_inverted_index.living | 75 |
| abstract_inverted_index.notion | 175 |
| abstract_inverted_index.sample | 69 |
| abstract_inverted_index.severe | 126 |
| abstract_inverted_index.social | 49, 118 |
| abstract_inverted_index.sought | 41 |
| abstract_inverted_index.suffer | 21 |
| abstract_inverted_index.trends | 192 |
| abstract_inverted_index.users, | 39 |
| abstract_inverted_index.Further | 226 |
| abstract_inverted_index.Methods | 63 |
| abstract_inverted_index.Results | 112 |
| abstract_inverted_index.anxiety | 120, 145 |
| abstract_inverted_index.current | 37 |
| abstract_inverted_index.extent, | 48 |
| abstract_inverted_index.greater | 22, 117 |
| abstract_inverted_index.illicit | 96, 155 |
| abstract_inverted_index.measure | 53 |
| abstract_inverted_index.results | 107 |
| abstract_inverted_index.steroid | 12 |
| abstract_inverted_index.suggest | 208 |
| abstract_inverted_index.systems | 211 |
| abstract_inverted_index.Abstract | 0 |
| abstract_inverted_index.Emerging | 4 |
| abstract_inverted_index.abnormal | 105, 161 |
| abstract_inverted_index.analyses | 114 |
| abstract_inverted_index.athletic | 31 |
| abstract_inverted_index.clinical | 230 |
| abstract_inverted_index.concerns | 19, 182 |
| abstract_inverted_index.consider | 215 |
| abstract_inverted_index.findings | 207 |
| abstract_inverted_index.increase | 195 |
| abstract_inverted_index.physical | 17 |
| abstract_inverted_index.physique | 50, 119, 144 |
| abstract_inverted_index.relation | 239 |
| abstract_inverted_index.research | 5 |
| abstract_inverted_index.results. | 163 |
| abstract_inverted_index.revealed | 115 |
| abstract_inverted_index.severity | 84 |
| abstract_inverted_index.suggests | 6 |
| abstract_inverted_index.symptoms | 127 |
| abstract_inverted_index.syndrome | 231 |
| abstract_inverted_index.uniquely | 122 |
| abstract_inverted_index.whether, | 44 |
| abstract_inverted_index.Australia | 203 |
| abstract_inverted_index.Moreover, | 134 |
| abstract_inverted_index.completed | 79 |
| abstract_inverted_index.concerns. | 34, 225 |
| abstract_inverted_index.conducted | 66 |
| abstract_inverted_index.determine | 43 |
| abstract_inverted_index.drinking, | 92, 153 |
| abstract_inverted_index.hazardous | 89, 150 |
| abstract_inverted_index.including | 28, 237 |
| abstract_inverted_index.non‐AAS | 95, 154 |
| abstract_inverted_index.required, | 236 |
| abstract_inverted_index.Australia. | 77 |
| abstract_inverted_index.Discussion | 164 |
| abstract_inverted_index.Interviews | 64 |
| abstract_inverted_index.appearance | 18, 55, 181, 224 |
| abstract_inverted_index.associated | 57, 123, 148 |
| abstract_inverted_index.consistent | 172 |
| abstract_inverted_index.dependence | 131, 234 |
| abstract_inverted_index.disorders. | 245 |
| abstract_inverted_index.elsewhere, | 205 |
| abstract_inverted_index.experience | 16, 180, 223 |
| abstract_inverted_index.heightened | 185 |
| abstract_inverted_index.indicating | 193 |
| abstract_inverted_index.prevalence | 198 |
| abstract_inverted_index.Conclusions | 166 |
| abstract_inverted_index.Limitations | 167 |
| abstract_inverted_index.co‐morbid | 188 |
| abstract_inverted_index.dependence, | 87 |
| abstract_inverted_index.depression, | 88 |
| abstract_inverted_index.depression. | 133 |
| abstract_inverted_index.dysfunction | 24 |
| abstract_inverted_index.established | 52 |
| abstract_inverted_index.instruments | 81 |
| abstract_inverted_index.Introduction | 1 |
| abstract_inverted_index.Multivariate | 113 |
| abstract_inverted_index.anxiety—an | 51 |
| abstract_inverted_index.dysfunction. | 60, 190 |
| abstract_inverted_index.occupational | 33 |
| abstract_inverted_index.prioritising | 216 |
| abstract_inverted_index.concern—was | 56 |
| abstract_inverted_index.health‐care | 210 |
| abstract_inverted_index.investigation | 227 |
| abstract_inverted_index.psychological | 23, 59, 98, 158, 189 |
| abstract_inverted_index.relationships | 140 |
| abstract_inverted_index.self‐report | 80 |
| abstract_inverted_index.side‐effects | 99, 159 |
| abstract_inverted_index.notwithstanding, | 168 |
| abstract_inverted_index.sub‐population | 9, 218 |
| abstract_inverted_index.sub‐populations, | 27 |
| abstract_inverted_index.anabolic–androgenic | 11 |
| cited_by_percentile_year.max | 99 |
| cited_by_percentile_year.min | 96 |
| corresponding_author_ids | https://openalex.org/A5000633656, https://openalex.org/A5060125444, https://openalex.org/A5007290128, https://openalex.org/A5090118852, https://openalex.org/A5015979821 |
| countries_distinct_count | 2 |
| institutions_distinct_count | 5 |
| corresponding_institution_ids | https://openalex.org/I165779595, https://openalex.org/I180670191, https://openalex.org/I31746571, https://openalex.org/I4210136824, https://openalex.org/I68435313 |
| sustainable_development_goals[0].id | https://metadata.un.org/sdg/3 |
| sustainable_development_goals[0].score | 0.8299999833106995 |
| sustainable_development_goals[0].display_name | Good health and well-being |
| citation_normalized_percentile.value | 0.93631498 |
| citation_normalized_percentile.is_in_top_1_percent | False |
| citation_normalized_percentile.is_in_top_10_percent | True |